Boston's resTORbio Sets Terms for $85M IPO Post author:Sam Post published:January 16, 2018 Post category:BioPharma resTORbio is developing novel therapies to improve immune function in the elderly. Source: BioSpace You Might Also Like Vioguard Signs Agreement With Of Saudi Arabia To Represent Vioguard In The Middle East April 2, 2017 It's Official: Ovid CEO Just Filed for $86 Million IPO April 11, 2017 Big Names in Biotech Seek $1M to Build Life-Size Statue of Legend Henri Termeer January 24, 2018
